1. |
Minic S, Obradovic M, Kovacevic I, et al. Ocular anomalies in incontinentia pigmenti:literature review and meta-analysis[J]. Srp Arh Celok Lek, 2010, 138(7-8):408-413.
|
2. |
O'Doherty M, Mc Creery K, Green AJ, et al. Incontinentia pigmenti--ophthalmological observation of a series of cases and review of the literature[J]. Br J Ophthalmol, 2011, 95(1):11-16.
|
3. |
Fusco F, Paciolla M, Pescatore A, et al. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with incontinentia pigmenti[J]. Hum Mutat, 2009, 30(9):1284-1291.
|
4. |
Ranchod TM, Trese MT. Regression of retinal neovascularization after laser photocoagulation in incontinentia pigmenti[J]. Retina, 2010, 30(4):708-709.
|
5. |
Rahi J, Hungerford J. Early diagnosis of the retinopathy of incontinentia pigmenti:successful treatment by cryotherapy[J]. Br J Ophthalmol, 1990, 74(6):377-379.
|
6. |
Mintz-Hittner HA, Kennedy KA, Chuang AZ, et al. Efficacy of intravitreal bevacizumab for stage 3+retinopathy of prematurity[J]. N Engl J Med, 2011, 364(7):603-615.
|
7. |
Wu WC, Kuo HK, Yeh PT, et al. An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in taiwan[J]. Am J Ophthalmol, 2013, 155(1):150-158.
|
8. |
Lin KL, Hirose T, Kroll AJ, et al. Prospects for treatment of pediatric vitreoretinal diseases with vascular endothelial growth factor inhibition[J]. Semin Ophthalmol, 2009, 24(2):70-76.
|